ENVX vs. VRTX
ENVX (Enovix Corp) and VRTX (Vertex Pharmaceuticals Incorporated) are both stocks. ENVX operates in Electrical Equipment & Parts (Industrials), while VRTX operates in Biotechnology (Healthcare). Over the past 3 years, ENVX returned -10.01%/yr vs 9.72%/yr for VRTX. At a 0.10 correlation, their price movements are largely independent.
Performance
ENVX vs. VRTX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ENVX achieves a 14.36% return, which is significantly higher than VRTX's -2.56% return.
ENVX
- 1D
- 1.58%
- 1M
- 21.51%
- YTD
- 14.36%
- 6M
- -8.03%
- 1Y
- 13.07%
- 3Y*
- -10.01%
- 5Y*
- —
- 10Y*
- —
VRTX
- 1D
- 3.13%
- 1M
- 4.10%
- YTD
- -2.56%
- 6M
- -3.42%
- 1Y
- -0.92%
- 3Y*
- 9.72%
- 5Y*
- 16.04%
- 10Y*
- 16.48%
ENVX vs. VRTX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
ENVX Enovix Corp | 14.36% | -23.14% | -13.18% | 0.64% | -54.40% | 53.86% |
VRTX Vertex Pharmaceuticals Incorporated | -2.56% | 12.58% | -1.03% | 40.90% | 31.50% | 9.75% |
Correlation
The correlation between ENVX and VRTX is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.07 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.10 |
Correlation (All Time) Calculated using the full available price history since Jul 16, 2021 | 0.10 |
Fundamentals
ENVX:
$1.82B
VRTX:
$113.22B
ENVX:
-$183.56
VRTX:
$16.87
ENVX:
0.23
VRTX:
9.27
ENVX:
0.01
VRTX:
4.27
ENVX:
$7.63B
VRTX:
$12.26B
ENVX:
$1.56B
VRTX:
$10.57B
ENVX:
-$43.98B
VRTX:
$5.19B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ENVX vs. VRTX — Risk / Return Rank
ENVX
VRTX
ENVX vs. VRTX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Enovix Corp (ENVX) and Vertex Pharmaceuticals Incorporated (VRTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ENVX | VRTX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +0.18 | ||
| Sortino ratioReturn per unit of downside risk | +0.66 | ||
| Omega ratioGain probability vs. loss probability | 1.11 | 1.03 | +0.07 |
| Calmar ratioReturn relative to maximum drawdown | 0.19 | -0.04 | +0.23 |
| Martin ratioReturn relative to average drawdown | 0.28 | -0.08 | +0.36 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ENVX | VRTX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.15 | -0.03 | +0.18 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.56 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.50 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.13 | 0.25 | -0.38 |
Drawdowns
ENVX vs. VRTX - Drawdown Comparison
The maximum ENVX drawdown since its inception was -84.76%, smaller than the maximum VRTX drawdown of -91.77%. Use the drawdown chart below to compare losses from any high point for ENVX and VRTX.
Loading charts...
Drawdown Indicators
| ENVX | VRTX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -84.76% | -91.77% | +7.01% |
Max Drawdown (1Y)Largest decline over 1 year | -69.62% | -23.56% | -46.06% |
Max Drawdown (3Y)Largest decline over 3 years | -75.42% | -29.07% | -46.35% |
Max Drawdown (5Y)Largest decline over 5 years | — | -29.07% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -41.60% | — |
Current DrawdownCurrent decline from peak | -73.33% | -14.51% | -58.82% |
Average DrawdownAverage peak-to-trough decline | -62.53% | -37.70% | -24.83% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 46.77% | 11.17% | +35.60% |
Volatility
ENVX vs. VRTX - Volatility Comparison
Enovix Corp (ENVX) has a higher volatility of 28.99% compared to Vertex Pharmaceuticals Incorporated (VRTX) at 7.54%. This indicates that ENVX's price experiences larger fluctuations and is considered to be riskier than VRTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ENVX | VRTX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 28.99% | 7.54% | +21.45% |
Volatility (6M)Calculated over the trailing 6-month period | 57.31% | 21.84% | +35.47% |
Volatility (1Y)Calculated over the trailing 1-year period | 87.10% | 34.02% | +53.08% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 93.44% | 28.94% | +64.50% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 93.44% | 32.83% | +60.61% |
Dividends
ENVX vs. VRTX - Dividend Comparison
Neither ENVX nor VRTX has paid dividends to shareholders.
Financials
ENVX vs. VRTX - Financials Comparison
This section allows you to compare key financial metrics between Enovix Corp and Vertex Pharmaceuticals Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
ENVX and VRTX have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ENVX has higher volatility (28.99%) compared to VRTX (7.54%). In terms of maximum drawdown, ENVX dropped -84.76% vs VRTX's -91.77%.
ENVX currently has the higher Sharpe Ratio (0.15 vs -0.03), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ENVX and VRTX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer